Australian Pharmaceuticals & Biotech Breakout Stocks

Results

2 new

Stocks where the price continues to rise after more than a year of consistent gains.

2 companies

PYC Therapeutics

Market Cap: AU$2.0b

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

PYC

AU$2.00

22.8%

66.3%

Nyrada

Market Cap: AU$183.9m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

NYR

AU$0.74

43.3%

132.8%